MedTrace Logo

Oral vs Intravenous Acetominophen for Postoperative Pain in Minimally Invasive Gynecologic Surgery

NCT03391284 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2022-11-22

No results posted yet for this study

Summary

Hypothesis: Postoperative pain will be equivalent in patients receiving preemptive oral acetaminophen as compared to patients receiving preemptive intravenous acetaminophen following minimally invasive benign gynecologic surgery.

Primary outcome:

• Difference in postoperative pain comparing preemptive use of PO versus IV acetaminophen

o Mean Visual analog Scale (VAS) scores will be compared between the intervention group (PO acetaminophen) and the control group (IV acetaminophen).

Secondary outcomes:

* Difference in postoperative analgesic use between groups

o Narcotics, NSAIDs
* Difference in postoperative N/V between groups

o Patient rated measure - none, mild, moderate, severe
* Cost comparison between drugs

Conditions

  • Post-operative Pain

Interventions

DRUG

acetominophen

INTRAVENOUS

DRUG

Acetaminophen

ORAL

Sponsors & Collaborators

  • Scripps Health

    lead OTHER

Principal Investigators

  • Bruce Kahn, MD · Scripps

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03391284 on ClinicalTrials.gov